Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Virology

• Publication date

  2010-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01087-10PMID 20592088PMCID PMC2937608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Summary of

  2011cited by this paper
• Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease.

  2010influential reference
• Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses

  2010influential reference
• Dengue vaccine candidates in development.

  2010cited by this paper
• Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification

  2010cited by this paper
• The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

  2010cited by this paper
• Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.

  2009cited by this paper
• Association of the pr Peptides with Dengue Virus at Acidic pH Blocks Membrane Fusion

  2009cited by this paper
• The Production of Antibody by Invading B Cells Is Required for the Clearance of Rabies Virus from the Central Nervous System

  2009cited by this paper
• Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step

  2009influential reference
• Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody

  2009cited by this paper
• A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes

  2009cited by this paper
• Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion

  2009cited by this paper
• Fusion Loop Peptide of the West Nile Virus Envelope Protein Is Essential for Pathogenesis and Is Recognized by a Therapeutic Cross-Reactive Human Monoclonal Antibody1

  2009cited by this paper
• Passive Protection Assay of Monoclonal Antibodies Against Dengue Virus in Suckling Mice

  2009cited by this paper
• On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes.

  2009cited by this paper
• Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection

  2008cited by this paper
• Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

  2008cited by this paper
• Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo

  2008cited by this paper
• Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins

  2008influential reference
• Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation

  2008cited by this paper
• Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains.

  2008cited by this paper
• Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus

  2008influential reference
• The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation

  2008cited by this paper
• Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

  2008cited by this paper
• Geographic expansion of dengue: the impact of international travel.

  2008cited by this paper
• A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles.

  2007cited by this paper
• Maternal antibody and viral factors in the pathogenesis of dengue virus in infants.

  2007cited by this paper
• Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection

  2007cited by this paper
• Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.

  2007influential reference
• Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus.

  2007cited by this paper
• Prospects for a dengue virus vaccine

  2007cited by this paper
• Essential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral Propagation

  2007influential reference
• Epitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized Antibody

  2007cited by this paper
• Probing the Flavivirus Membrane Fusion Mechanism by Using Monoclonal Antibodies

  2007cited by this paper
• Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes

  2007influential reference
• A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.

  2006cited by this paper
• Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein

  2006cited by this paper
• Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN.

  2006influential reference
• Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

  2006cited by this paper
• Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein

  2005cited by this paper
• Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

  2005cited by this paper
• Structure of the dengue virus envelope protein after membrane fusion

  2004cited by this paper
• Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical

  2004cited by this paper
• Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes

  2004cited by this paper
• Epitope Determinants of a Chimpanzee Fab Antibody That Efficiently Cross-Neutralizes Dengue Type 1 and Type 2 Viruses Map to Inside and in Close Proximity to Fusion Loop of the Dengue Type 2 Virus Envelope Glycoprotein

  2004cited by this paper
• Solution Structure and Antibody Binding Studies of the Envelope Protein Domain III from the New York Strain of West Nile Virus*

  2004cited by this paper
• Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses.

  2004cited by this paper
• Microevolution and virulence of dengue viruses.

  2003cited by this paper
• Structures of immature flavivirus particles

  2003cited by this paper
• A ligand-binding pocket in the dengue virus envelope glycoprotein

  2003cited by this paper
• DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells

  2003influential reference
• The origin, emergence and evolutionary genetics of dengue virus.

  2003cited by this paper
• B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus

  2003cited by this paper
• Dendritic‐cell‐specific ICAM3‐grabbing non‐integrin is essential for the productive infection of human dendritic cells by mosquito‐cell‐derived dengue viruses

  2003influential reference
• Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.

  2002cited by this paper
• Identification of Neutralizing Epitopes within Structural Domain III of the West Nile Virus Envelope Protein

  2002cited by this paper
• Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism.

  2001cited by this paper
• Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies.

  2001cited by this paper
• Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

  2001cited by this paper
• Dengue Virus Structural Differences That Correlate with Pathogenesis

  1999cited by this paper
• Analysis of the steps involved in Dengue virus entry into host cells.

  1999cited by this paper
• New Mouse Model for Dengue Virus Vaccine Testing

  1999cited by this paper
• Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.

  1998cited by this paper
• Characterization of dengue virus envelope protein.

  1997cited by this paper
• A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice.

  1996cited by this paper
• Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge.

  1994cited by this paper
• 25 Antibody-dependent Enhancement of Infection: A Mechanism for Indirect Virus Entry into Cells

  1994cited by this paper
• Cellular receptors for animal viruses

  1994cited by this paper
• Molecular evolution and distribution of dengue viruses type 1 and 2 in nature.

  1990cited by this paper
• Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.

  1989cited by this paper
• Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model

  1989cited by this paper
• Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release

  1989cited by this paper
• Antibodies: A Laboratory Manual

  1988cited by this paper
• Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection.

  1987cited by this paper
• Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate.

  1984cited by this paper

• Efficacy of Multivalent Dengue Vaccine Candidates Predicted In Silico.

  2026cites this paper
• Neutralizing monoclonal antibodies against dengue virus: a scoping review of preclinical and clinical development.

  2025cites this paper
• Identification of a novel linear B-cell epitope recognized by a monoclonal antibody against the capsid protein of goose astrovirus genotypes 2

  2025cites this paper
• B-cell epitope mapping of VP5 protein of bluetongue virus serotype 1 using monoclonal antibodies

  2025cites this paper
• Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domains

  2025cites this paper
• Dengue virus infection: A systematic review of pathogenesis, diagnosis and management.

  2025cites this paper
• Design of Hyperglycosylated Zika Virus E Proteins that Focus Antibody Recognition on the Complex E Dimer Epitope.

  2025cites this paper
• Structure-based identification of small-molecule inhibitors that target the DIII domain of the Dengue virus glycoprotein E pan-serotypically

  2024cites this paper
• Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection

  2024influential citation
• Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection

  2024influential citation
• Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies

  2024cites this paper
• Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement

  2023influential citation
• prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis

  2023cites this paper
• Computer-aided Affinity Enhancement of a Cross-reactive Antibody against Dengue Virus Envelope Domain III

  2023cites this paper
• Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection

  2023cites this paper
• Defining the impact of flavivirus envelope protein glycosylation on sensitivity to broadly neutralizing antibodies

  2023cites this paper
• Beneath the surface: Amino acid variation underlying two decades of dengue virus antigenic dynamics in Bangkok, Thailand

  2022cites this paper
• A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.

  2022cites this paper
• Characterization of a universal neutralizing monoclonal antibody against Glaesserella parasuis CdtB.

  2022cites this paper
• Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo.

  2022cites this paper
• Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences

  2022cites this paper
• Vaccination with a Zika virus envelope domain III protein induces neutralizing antibodies and partial protection against Asian genotype in immunocompetent mice

  2022cites this paper
• Identification of the mimotopes within the major capsid protein L1 of human papillomavirus types 18 and 45, using neutralizing monoclonal antibodies.

  2021cites this paper
• Immune profile and responses of a novel Dengue DNA vaccine encoding EDIII-NS1 consensus design based on Indo-African sequences

  2021cites this paper
• Structural and Biochemical Insights Into Flavivirus Proteins.

  2021cites this paper
• Identification of a novel B cell epitope on the nucleocapsid protein of porcine deltacoronavirus

  2021influential citation
• Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.

  2021cites this paper
• Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera

  2021cites this paper
• Molecular dynamics simulations and Gaussian network model for designing antibody mimicking protein towards dengue envelope protein

  2021cites this paper
• Hydrogen-deuterium exchange mass spectrometry identifies spatially distinct antibody epitopes on domain III of the Zika virus envelope protein.

  2020cites this paper
• Identification of a novel epitope specific for Gp85 protein of avian leukosis virus subgroup K.

  2020cites this paper
• Dengue Immunopathogenesis: A Crosstalk between Host and Viral Factors Leading to Disease: PART II - DENV Infection, Adaptive Immune Responses, and NS1 Pathogenesis

  2020cites this paper
• A complex between the Zika virion and the Fab of a broadly cross-reactive neutralizing monoclonal antibody revealed by cryo-EM and single particle analysis at 4.1 Å resolution

  2020cites this paper
• Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

  2020cites this paper
• Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees

  2020cites this paper
• Production and immunogenicity of Fubc subunit protein redesigned from DENV envelope protein

  2020cites this paper
• Dengue and Zika virus multi-epitope antigen expression in insect cells

  2020cites this paper
• Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4+ T Cells to the Dengue Virus Envelope Protein Domain III

  2019cites this paper
• Screening and identification of RhD antigen mimic epitopes from a phage display random peptide library for the serodiagnosis of haemolytic disease of the foetus and newborn.

  2019cites this paper
• Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics

  2019cites this paper
• Identification of three linear B cell epitopes using monoclonal antibodies against bovine enterovirus VP2 protein

  2019cites this paper
• Identification of a conserved linear epitope using monoclonal antibody against non-structural protein 3A of foot-and-mouth disease virus with potential for differentiation between infected and vaccinated animals.

  2019cites this paper
• Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge

  2019cites this paper
• A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III

  2019cites this paper
• Dengue proteins with their role in pathogenesis, and strategies for developing an effective anti‐dengue treatment: A review

  2019cites this paper
• Functional characterization and lineage analysis of broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics

  2019cites this paper
• A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice

  2018cites this paper
• Naïve Human Antibody Libraries for Infectious Diseases

  2018cites this paper
• Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus

  2018cites this paper
• Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo

  2018cites this paper
• The Many Faces of a Dynamic Virion: Implications of Viral Breathing on Flavivirus Biology and Immunogenicity.

  2018cites this paper
• Identification of antigenic epitopes of monoclonal antibodies against the VP2 protein of the 25 serotype of bluetongue virus.

  2018cites this paper
• Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.

  2018cites this paper
• Immunomodulatory Functions of the Gastrointestinal Tract

  2018cites this paper
• 3H5 Fab bound to EDIII of DenV 2 Xtal form 2

  2018cites this paper
• Size-dependent neutralizing activity of gold nanoparticle-based subunit vaccine against dengue virus.

  2018cites this paper
• Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions

  2018cites this paper
• Recent Developments in Recombinant Protein–Based Dengue Vaccines

  2018cites this paper
• Antibody-dependent enhancement of severe dengue disease in humans

  2017cites this paper
• Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice

  2017cites this paper
• Immune Human Antibody Libraries for Infectious Diseases.

  2017cites this paper
• Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity

  2017cites this paper
• Generation and mimotope identification of agylcosylated neutralizing human monoclonal antibody against 4 serotypes of dengue virus without

  2017cites this paper
• A synthetic peptide derived from domain III envelope glycoprotein of Dengue virus induces neutralizing antibody

  2017cites this paper
• Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.

  2017cites this paper
• Vaccines licensed and in clinical trials for the prevention of dengue

  2017cites this paper
• Neutralizing and enhancing antibody responses to five genotypes of dengue virus type 1 (DENV-1) in DENV-1 patients.

  2017cites this paper
• A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus

  2017cites this paper
• Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.

  2017cites this paper
• Evaluation of a Tetravalent DNA Vaccine against Dengue: Integrating Biochemical Studies on Dengue Virus Envelope Protein to a Domain-Based Antigen Design.

  2017cites this paper
• DEVELOPMENT OF IMMUNOCHROMATOGRAPHIC STRIP TEST FOR DENGUE VIRUS DETECTION

  2017cites this paper
• Construct and expression of recombinant domains I/II of dengue virus- 2 and its efficacy to evaluate immune response in endemic area: Possible use in prognosis.

  2017cites this paper
• Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement

  2017cites this paper
• Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies

  2017cites this paper
• Development of Antibody Therapeutics against Flaviviruses

  2017influential citation
• Identification of two conserved B-cell epitopes in the gp90 of reticuloendothelial virus using peptide microarray.

  2017cites this paper
• Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques

  2017cites this paper
• Identification of a serotype-independent linear epitope of foot-and-mouth disease virus

  2017cites this paper
• Review of Current Non-Vaccine Based Approaches for the Prevention and Treatment of Flaviviral Diseases

  2017cites this paper
• Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development

  2017cites this paper
• Identification of a novel linear B-cell epitope in the p27 of Avian leukosis virus.

  2017cites this paper
• Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus

  2017cites this paper
• Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.

  2017cites this paper
• Relative contribution of dengue prM- and E-specific polyclonal antibodies to neutralization and enhancement.

  2016cites this paper
• Animal models of yellow fever and their application in clinical research.

  2016cites this paper
• Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity

  2016cites this paper
• The development of therapeutic antibodies against dengue virus.

  2016cites this paper
• New insights into dengue pathogenesis and control

  2016cites this paper
• Generation and characterization of a monoclonal antibody against duck Tembusu virus envelope protein.

  2016cites this paper
• Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses

  2016cites this paper
• Therapeutic monoclonal antibody for dengue treatment

  2016cites this paper
• Evolutionarily Successful Asian 1 Dengue Virus 2 Lineages Contain One Substitution in Envelope That Increases Sensitivity to Polyclonal Antibody Neutralization.

  2016cites this paper
• A Conserved Epitope Mapped with a Monoclonal Antibody against the VP3 Protein of Goose Parvovirus by Using Peptide Screening and Phage Display Approaches

  2016cites this paper
• Structural Basis of Zika Virus-Specific Antibody Protection.

  2016influential citation
• Engineered DNA-mediated antibody gene transfer for prophylaxis against infectious diseases

  2016cites this paper
• Next generation dengue vaccines: A review of the preclinical development pipeline.

  2015cites this paper
• A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

  2015cites this paper
• An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2

  2015cites this paper
• Identification of a novel B-cell epitope specific for avian leukosis virus subgroup J gp85 protein

  2015cites this paper
• Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection

  2015cites this paper